NovaBay Pharmaceuticals, Inc. Capex per Share

Capex per Share of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex per Share growth rates and interactive chart. Capex per share refers to the total amount of capital expenditures paid in a period divided by the weighted average number of shares outstanding. If a company has capex of $100 million and 10 million shares outstanding, capex per share is $10.


Highlights and Quick Summary

  • Capex per Share for the quarter ending September 30, 2022 was -0.05 (a 841.51% increase compared to previous quarter)
  • Year-over-year quarterly Capex per Share increased by 704.84%
  • Annual Capex per Share for 2021 was -0.04 (a 61.0% increase from previous year)
  • Annual Capex per Share for 2020 was -0.03 (a -15.64% decrease from previous year)
  • Annual Capex per Share for 2019 was -0.03 (a -66.26% decrease from previous year)
  • Twelve month Capex per Share ending September 30, 2022 was -0.07 (a 97.88% increase compared to previous quarter)
  • Twelve month trailing Capex per Share increased by 86.07% year-over-year
Trailing Capex per Share for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-0.07 -0.04 -0.04 -0.04
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex per Share of NovaBay Pharmaceuticals, Inc.

Most recent Capex per Shareof NBY including historical data for past 10 years.

Interactive Chart of Capex per Share of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Capex per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.05 -0.01 -0.02
2021 -0.01 -0.01 0.0 -0.0 -0.04
2020 -0.0 0.0 0.0 0.0 -0.03
2019 0.0 0.0 -0.0 -0.0 -0.03
2018 -0.0 -0.0 0.0 0.0 -0.09
2017 -0.0 -0.0 -0.01 -0.0 -0.56
2016 -0.01 -0.0 -0.0 -0.0 -0.02
2015 -0.03 -0.01 -0.0 0.01 -0.03
2014 0.01 -0.02 0.05 -0.01 0.03
2013 -0.07 -0.0 -0.01 -0.01 -0.09
2012 -0.08 -0.04 -0.0 0.0 -0.12
2011 -0.0 -0.12

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology